Category: Healthcare

Healthcare

Nebulizers Market: Technological Advancements in Respiratory Equipment to Drive Global Market

Nebulizers are devices used for spraying liquid evenly in medicinal drugs for inhaling or other purposes. A nebulizer is a device that changes liquid medicine into a mist that is then inhaled via a mask or a mouthpiece. As asthma medication is sometimes prescribed via nebulizer, it holds a significant share on account of the increasing rate of patients suffering from asthma. Respiratory problems that results from smoking habits, changing lifestyle, and long term exposure to environmental pollution are projected to serve as the key factors augmenting the sales growth of the global nebulizers market in the near future.

Owing to the rising prevalence of respiratory disorders such as COPD, asthma, and cystic fibrosis, there is a growing demand for nebulizers all over the world. Technological innovations in medical devices, hugely profitable presence of both regional and international players are likely to serve as the emerging trends of the nebulizers market. Additionally, the rise in geriatric patients globally is also contributing to future market growth.

The advent of advanced manufacturing processes is creating revenue generation opportunities for the nebulizers market as well as for other medical device manufacturers. In the coming years, major advancements in respiratory medical devices are predicted to boost the global nebulizer market. To meet the demands of the healthcare sector, some players of the global nebulizers market are expanding their product portfolio and offer better quality products in the coming years. For instance, The production of an advanced hydrogen-oxygen AMS-H-03 nebulizer was announced in April 2020 by Asclepius Meditech Co. Ltd. This nebulizer will help in the treatment of COVID19 patients reduce the shortage of ventilators in China.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1436

The nature of the nebulizers market is highly fragmented on account of the presence of multiple players. Companies are investing in improving product portfolio and brand expansion to gain significant position in the overall market competition. Other players are making heavy investments on research and development for the manufacturing of advanced products. Some of the key players of the global nebulizers market include Philips Healthcare, PARI Respiratory Equipment Inc., Omron Healthcare Inc., GF Health Products Inc., GE Healthcare Ltd., Covidien Plc., CareFusion Corporation, Allied Healthcare Products Inc., and others.

High Prevalence of Respiratory Diseases will Augment Growth of Market

North America had the highest number of asthma and COPD cases in the world in 2012, as per the Centers for Disease Control and Prevention (CDC). Asthma, cystic fibrosis, and COPD are becoming increasingly common around the world. Their prevalence will help increase the sales projections of the nebulizers market in the long run.  The exact cause of asthma and cystic fibrosis is unknown; however, risk factors include hereditary conditions (inherited from parents) and environmental pollution (chemical irritant or UV ray). COPD, on the other hand, is primarily caused by cigarette smoking. This implies that the rise in number of smoker’s population will also have an indirect but positive influence on the overall growth of this market.

Make an Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1436

Geographically, The Asia Pacific nebulizers market is expected to grow rapidly due to factors such as the incidences of respiratory disorders such as asthma and bronchitis, rising demand for targeted therapies, growing healthcare awareness, and rising disposable income.  Furthermore, healthcare and economic development reforms would increase government funding for intensive R&D, thereby, helping this region emerge as the fastest growing market for nebulizers in the coming years. On the other side, the market in North America will witness significant growth prospects in the next couple of years. This is accountable to an increase in the incidence of various respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. Other factors driving market growth in the region include technological advancements in healthcare and increased adoption

Meningococcal Vaccines Market: Increase in Awareness about Disease and Growth in Marketing Approvals to Boost Market

Meningococcal vaccines are utilized to prevent infections induced by N. meningitides, such as septicemia, meningococcemia, and meningitis. Meningococcal disease, mainly meningococcal meningitis, is highly communicable between groups or individuals. To date, several meningococcal serogroups have been found, with serogroups A, B, C, Y, and W-135 being the most common causes.

Meningococcal illness is uncommon, although it has a casualty rate of 10% to 20%. It usually causes significant problems if left unchecked. Meningococcal meningitis is an infection of the spinal cord and brain lining. It has the possibility of causing large-scale breakouts and endemic diseases. Annually, 15 to 20 people die from meningococcal disease. Moreover, one in every five survivors has long-term issues such as brain damage, deafness, seizures, or limb loss. As a result, global demand for meningococcal vaccines is skyrocketing.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666

The National Meningitis Association (NMA) promotes teamwork by providing chances to collaborate with corporations, government agencies, and other non-profit organizations to promote awareness regarding meningococcal disease, preventative measures, and the crucial need for emergency treatment after diagnosis. Furthermore, the Meningitis Foundation of America (MFA) is a non-profit organization that offers meningitis patients guidance and assistance. The organization also works to increase public and medical knowledge of the early signs of meningitis. As a result, the global meningococcal vaccines market is projected to grow over the forecast period.

The meningococcal vaccines market is anticipated to reach USD 9.2 billion by the end of 2031, expanding at a CAGR of 9.4% from 2022 to 2031 (forecast period).

Strong Focus on Developing Innovative Vaccines to Boost Market Growth
Companies’ increased emphasis on developing innovative vaccines for meningococcal illness is expected to boost the sales of meningococcal vaccines market during the forecast period. In April 2022, for example, researchers from the University of Maryland School of Medicine (UMSOM) launched new research in which they are assessing the five-in-one meningococcal conjugate vaccination (NmCV-5) or pentavalent among newborns and young children in Sub-Saharan Africa’s meningitis belt. This is the final study for achieving World Health Organization prequalification for this vaccine, and if it does, it will be introduced in low- and middle-income nations. As a result of such novel vaccines, the global meningococcal vaccines market is anticipated to expand during the forecast period.

North America to Dominate Meningococcal Vaccines Market

North America is set to dominate the global meningococcal vaccines market during the forecast period. The United States is likely to be the largest revenue generator in meningococcal vaccines market in North America due to increased illness awareness and improved healthcare facilities. According to data given by the CDC (Centers for Disease Control and Prevention), there was a meningococcal disease outbreak in Florida, United States, in 2021. To combat this outbreak, the CDC advised bisexual and homosexual males in Florida to get the MenACWY vaccine. It raised public awareness, which increased the demand for meningococcal vaccines in the country.

Make an Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1666

Since the United States has a well-established healthcare system, vaccination is a top priority for the country’s government. As a consequence, timely immunization is conducted in the United States, contributing to the country’s meningococcal vaccines market growth. In the United States, for example, the Meningitis Foundation of America (MFA) is a non-profit organization that strives to provide information and assistance to people affected by meningitis. This organization also aims to raise public and medical knowledge about the early symptoms of meningitis. As a result of the aforementioned factors, the global meningococcal vaccines market is likely to rise steadily over the forecast period.

Moreover, Europe is expected to contribute to the global meningococcal vaccines market during the forecast period.

Pain Management Devices Market – Competitive Analysis with Forecast to 2031

Pain management devices are utilized for treating both acute and chronic pain among patients with a variety of medical conditions, including musculoskeletal disorders, neurological disorders, and cancer. These devices restore patients’ ability to perform daily activities, reduce the demand for oral medicine, and enhance their life quality. The percentage of surgical procedures performed around the world has risen significantly over the years. This can be attributed to an ageing population as well as an increase in the prevalence of obesity and other lifestyle diseases.

Obesity is a major contributor to orthopedic and cardiovascular diseases. The primary application area for infusion pumps is analgesia or pain management. Infusion pumps are also commonly used for general anesthesia and narcotic analgesic administration following bariatric surgery, laparoscopic cholecystectomy, and cardiothoracic surgery.

North America stands dominant for the pain management devices market on account of the presence of well-established medical infrastructure, coupled with major advancements in pain management and interminable ailments. High prevalence of diseases related to obesity will also promote growth. Additionally, the advent of cutting-edge innovative technologies for medical use in diagnostics or therapy will further help this region continue to dominate the market in the near future.

The increasing prevalence of trauma, neurological diseases, arthritis, and cancer are contributing significantly to the sales growth of the pain management device market. The introduction of advanced healthcare facilities and an increase in the number of hospitals worldwide will also create revenue generation opportunities for the pain management device market in the near future. Besides this, the rising prevalence of sports-related injuries and lifestyle-related diseases is propelling the growth as well. Furthermore, the presence of a large patient pool, coupled with the adverse effects of pain medications, and the high proven performance of pain management devices are likely to serve as the emerging trends in the global pain management devices market.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1143

However, factors such as the absence of pain clinics in several underdeveloped and emerging countries, and the scarcity of pain management specialists in healthcare setups and hospitals may pose significant challenges to the overall growth of this market. In addition to this, the presence of an unaware patient pool, the unavailability of pain management devices, and the lack of government support in most emerging and underdeveloped economies may also cause major hindrances to the overall growth of the market besides the high cost of pain management devices.

Fierce Competition among Players will Bode Well for Future Revenue Generation

In the global pain management devices market, there is a notable presence of players. The global pain management devices market is defined by fierce competition among players. Many market participants are competing for the top position to strengthen their brand presence. As a result, they are focusing on releasing various types and executive devices with novel advancements in order to remain competitive in the global market. A few notable players are focusing on expanding their portfolio in order to consolidate their offers in the global market. In the coming years, rapidly increasing speculations on groundbreaking research exercises are likely to fuel the power of competition among leading players in the pain management devices market.

Make an Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1143

Few other players are engaging in new product development and innovation for different pain management problems to ensure they enhance their brand name in the market competition. For instance, NeuraLace Medical, Inc., a company dealing with medical devices, declared in May 2021 that the first patient had been enrolled in the AXON-RCT U.S. Axon Therapy helps to relieve severe nerve pain by supplying continuous and focused magnetic pulses that further activate the peripheral nerve axons which have been damaged. Some of the key players of the global pain management devices market include Microtransponde, Avanos Medical Inc., B. Braun Melsungen AG, Stryker Corporation, Medtronic Plc., DJO Global Inc., Boston Scientific Corporation, Bio-Medical Research (BMR) Ltd., Baxter International Inc., and others.

ASEAN Surgical Site Infections Market: Increase in Technologically Advanced Surgical Products to Boost the Global Market

Surgical procedures are preferred by a large number of people for different purposes. They are used for treating numerous diseases and disorders. The popularity of surgical procedures has risen considerably over the years. Hence, the expanding number of surgical procedures among a substantial chunk of the global populace coupled with the increasing geriatric population is estimated to serve as prominent growth-boosting factors for the global surgical site infections market in the upcoming period. A large number of healthcare organizations are getting to know the dangerous side effects of surgical site infections and are making proper arrangements for its prevention. Therefore, this aspect may provide substantial growth prospects for the surgical site infections market in future.

Surgical site infections can be described as a post-surgery infection. It spreads over the operated body organ. The consequences of the infection can be normal or superficial skin infections. In some cases, these infections can lead to serious issues that can damage organs and tissues under the skin or implanted material. Sometimes, the infection can also prove to be fatal. The reasons for occurrence can be attributed to factors such as contact of the wound with an infected object, utilization of non-surgical equipment, harmful bacteria entering the wound, and so on. Furthermore, surgical site infections are primary causes of morbidity and mortality, resulting in patient readmission post-surgery. All these factors may bring extensive growth opportunities for the surgical site infections market.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84827

The products used for treating surgical site infections are surgical drapes, clippers, antiseptics, clippers, wound care dressings, wound irrigation products, antibiotic prophylaxis products, and others. The prominent types of surgical site infections are space infection, superficial incisional infection, and deep incisional infection. The extensive use of surgical site infection services across clinics, hospitals, ambulatory surgical centers, and others will assure promising growth for the surgical site infections market. These infections are prominently caused through surgeries related to cataracts, cesarean section, dental restoration, and others.

Research and development activities are one of the prominent factors that have a profound impact on the overall growth trajectory of the surgical site infections market. The players invest extensively in these activities for expanding their scope across the developments in the technologies related to surgical site infections. Furthermore, strategic collaborations are also necessary for the players in the surgical site infections market. The players indulge in acquisitions, joint ventures, partnerships, and mergers for increasing their influence across untapped regions, ultimately contributing to the growth of the surgical site infections market.

Make an Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84827

High Number of Surgeries in Various Regions to Boost Growth of Surgical Site Infections Market

The number of surgeries conducted every year has gone up considerably over the years. The recent developments in the surgery sector have attracted many individuals to undergo surgeries. A key trend emerging across the globe is undergoing cosmetic surgery. This surgery causes surgical site infections on a large scale. In addition, high incidences of traumatic brain injury cases in regions such as Thailand, Australia, India, and China have resulted in frequent cases of surgical site infections. All these aspects bode well for the growth of the surgical site infections market.

Asia Pacific to Assure Promising Growth for Surgical Site Infections Market

An increase in road accidents has led to an increase in the number of surgeries across Asia Pacific, especially in China, Indonesia, and India. In addition, the geriatric population numbers are increasing at a rapid rate in Asia Pacific. Hence, these factors can prove to be crucial for Asia Pacific to emerge as a key growth-generating region for the surgical site infections market in the upcoming period.